Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 6/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
| ▸ | YAP1 | P46937 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21647850 | 1.00 | FKBP1A (0.34) | FKBP1ASLC6A3MEN1KMT2AKDM4C | |
| SCHEMBL29191833 | 1.00 | FKBP1A (0.34) | FKBP1ASLC6A3MEN1KMT2AKDM4C | |
| SCHEMBL23440877 | 0.89 | FFAR4 (0.39) | FKBP1ASLC6A3PTGER4 | |
| SCHEMBL23440879 | 0.89 | FFAR4 (0.39) | FKBP1ASLC6A3PTGER4 | |
| SCHEMBL21647729 | 0.87 | SLC6A3 (0.38) | SLC6A3MEN1KMT2APTGER4 | |
| SCHEMBL29483744 | 0.87 | SLC6A3 (0.38) | SLC6A3MEN1KMT2APTGER4 | |
| SCHEMBL29191834 | 0.85 | SLC6A3 (0.35) | SLC6A3KMT2APTGER4YAP1 | |
| SCHEMBL21647751 | 0.84 | KDM4C (0.34) | SLC6A3MEN1KMT2AKDM4CPTGER4 | |
| SCHEMBL21647752 | 0.84 | KDM4C (0.34) | SLC6A3MEN1KMT2AKDM4CPTGER4 | |
| SCHEMBL30409813 | 0.84 | KDM4C (0.34) | SLC6A3MEN1KMT2AKDM4CPTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188023-A1 | BENZENE DERIVATIVE | ONO PHARMACEUTICAL CO., LTD. (JP) | 2025-06-12 | — | — | US | disclosed |
| US-12258308-B2 | Benzene derivative | ONO PHARMACEUTICAL CO., LTD. (JP) | 2025-03-25 | — | — | US | disclosed |
| US-20220089532-A1 | BENZENE DERIVATIVE | ONO PHARMACEUTICAL CO., LTD. (JP) | 2022-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12258308-B2 | Benzene derivative | PMP22, TMBIM6, MYT1 | FKBP1A 2934/4885SLC6A3 2855/4885MEN1 2716/4885 |
| US-20250188023-A1 | BENZENE DERIVATIVE | PMP22, TMBIM6, MYT1 | FKBP1A 2923/4885SLC6A3 2807/4885MEN1 2705/4885 |
| US-20220089532-A1 | BENZENE DERIVATIVE | PMP22, TMBIM6, MYT1 | FKBP1A 2934/4885SLC6A3 2855/4885MEN1 2716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.